Article | February 23, 2022

How Microbial Fermentation And Protein Biomanufacturing Works

Source: Luina Bio
iStock-1219894397-lab-cleanroom-computer-team

Luina Bio’s manufacturing facility offers the latest fermentation technologies supported by world-renowned expertise in drug development and production

Microbial fermentation is the basis for the production of a wide variety of pharmaceutical drugs and biologics, from anti-cancer drugs and vaccines to hormonal disorder therapies and many others.

Over the past 10 years, more half of the 150 recombinant pharmaceutical products approved for human use by the US Food and Drug Administration and The European Medicines Agency were manufactured via microbial fermentation using bacteria or yeast1.

The global market for protein-based biologics derived from microbial fermentation, valued at US$44 billion in 2017, is projected to grow to US$60 billion by 2020, while the market for peptide hormones and vaccines is expected to increase from US$18 to US$28 billion and US$10 to US$19 billion, respectively, over the same period2.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: